Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

GABRA2 gene variations impact alcohol response, and hair loss medication finasteride reduces some effects.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

New alopecia treatments aim for better results and fewer side effects.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

A new hair loss treatment uses tiny needles to deliver a drug-loaded lipid carrier, promoting hair growth more effectively than current treatments.

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

Dutasteride works better than finasteride for hair loss, with both being safe to use.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Cacumen Platycladi oil promotes hair growth better than minoxidil.

Wheat straw is valuable for its health benefits and various industrial uses.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Combination therapies work better than single treatments for hair loss.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

Early diagnosis and treatment, like topical minoxidil, can prevent hair loss in children.

Topical cetirizine 1% promotes hair growth in male androgenetic alopecia patients.